Microprocessor-controlled knees: Symposium highlights clinical and economic findings

08.05.2026

Recent clinical and health economic findings on microprocessor-controlled knees (MPKs) were the focus of an online symposium held in late April 2026. Experts from prosthetics research, rehabilitation medicine and health economics discussed how MPKs may influence safety, mobility, quality of life and healthcare costs. The presentations highlighted existing evidence that advanced prosthetic knee technology can benefit users across different mobility levels.

Clinical evidence expands beyond highly active users

Elderly person with a lower limb prosthesis walks outdoors carrying a shopping bag in front of a modern building

Current research discussed during the symposium suggests that microprocessor-controlled knees may also benefit people with lower mobility levels, including K2 users. © Ottobock

During the online symposium, experts examined current research on microprocessor-controlled knees and their impact on prosthetic care. Discussions focused on biomechanical safety, fall prevention and the long-term economic implications of MPK provision compared with non-microprocessor knees (NMPKs).

Prof. Dr. Bernhard Greitemann (Specialist in Orthopedics, Physical and Rehabilitation Medicine, Pain Medicine, and Technical Orthopedics) emphasized that existing evidence already points to improvements in gait and reduced fall frequency among MPK users. In addition to clinical outcomes, the symposium also explored broader socioeconomic and reimbursement-related aspects of prosthetic provision.

From a biomechanical perspective, Prof. Malte Bellmann (Director of Clinical Research & Services Germany at Ottobock SE & Co. KGaA) highlighted the importance of safe and reliable prosthetic knee function in everyday movement situations. According to Bellmann, prosthetic safety is shaped not only by the technology itself, but also by the interaction between the prosthetic knee joint and the individual condition and mobility of the user.

Based on clinical experience and scientific evidence, Bellmann pointed out that conventional indication models are increasingly being challenged. The observed outcomes suggest that MPKs are not only beneficial for highly active amputees, but may also support people classified at mobility level K2.

Health economic analyses show long-term potential

A major focus of the symposium was the health economic evaluation of MPKs in different healthcare systems.

Prof. Dr. Alexander Kuhlmann (Professor of Health Economics at the University of Lübeck, Germany) presented comparative modelling analyses for Germany, the Netherlands and Sweden. His research examined how factors such as study duration, country-specific pricing and quality-of-life measurements influence the cost-effectiveness of MPKs compared with NMPKs.

According to Kuhlmann, the selected time horizon plays a particularly important role when evaluating technologies that may provide long-term clinical benefits. Under the assumption of sustained benefits, MPKs such as the C-Leg and Kenevo may be considered cost-effective below a threshold of €50,000 per quality-adjusted life year (QALY) gained.

The symposium also addressed economic findings from the United States. Steven E. Heath (Senior Data Manager at Dobson DaVanzo & Associates, LLC, USA) presented data on Medicare beneficiaries classified as mobility level K2. The analysis compared MPK provision with NMPKs and evaluated both healthcare expenditures and fall-related medical claims.

The presented data suggest that MPK provision for K2 users may contribute to improved clinical outcomes and cost savings for Medicare over time. According to the analysis, the adjusted additional costs associated with MPK provision could amortize after 19 months. The study also reported an 18.5 percent reduction in falls resulting in medical claims.

Key findings from the symposium

Existing evidence links MPKs to improved gait and reduced fall frequency
Experts highlighted safety and reliable prosthetic knee function as central aspects of MPKs
Current research increasingly supports MPK use beyond highly active amputees
Health economic analyses indicate potential long-term cost-effectiveness of MPKs
Studies presented at the symposium suggest possible Medicare savings alongside fewer fall-related medical claims